influenza

[Journal of Leukocyte Biology] Scientists present an overview of neutrophil heterogeneity and its impact on the course and severity of viral respiratory infectious diseases.

[Journal of Leukocyte Biology] Aiming to develop an effective vaccine with rapid production, robust immunogenicity, and high protective efficiency, a DNA vaccine was designed by fusing influenza virus hemagglutinin (HA) with self-assembled ferritin nanoparticles, denoted as HA-F.

[Journal of Immunology] Using miRNA microarray profiling, investigators characterized the expression profile of naive and in vivo generated murine effector antiviral CD8+ T cells.

[Scientific Reports] Scientists demonstrated the capability of Plasma Activated Media to inactivate SARS-CoV-2 and PR8 H1N1 influenza virus with negligible damage on healthy cells.

[The Scientist] The UK is experiencing its “largest ever” outbreak of avian influenza, BBC News reported in December, with more than 60 cases since the first report of infected swans in October.

[Proceedings of the National Academy of Sciences of the United States of America] A strong response was induced in monocytes and B cells, with a SARS-CoV-2–specific inflammatory gene cluster distinct from that seen in influenza A or Ebola virus-infected cocultures, and which reproduced deviations reported in blood or lung myeloid cells from COVID-19 patients.